122Indexed trials
canonical disease area
Substance Use Disorders
Intelligence
Substance Use Disorders intelligence: 122 indexed trials, 30 recruiting studies, 93 sponsors across 19 countries.
30Recruiting
93Sponsors
19Countries
Leading sponsors
Karolinska Institutet60 recruiting
Massachusetts General Hospital32 recruiting
Johns Hopkins University31 recruiting
Beijing Normal University30 recruiting
New York State Psychiatric Institute30 recruiting
National Institute on Drug Abuse (NIDA)30 recruiting
Medical University of South Carolina30 recruiting
Yale University31 recruiting
National Institute on Alcohol Abuse and Alcoholism (NIAAA)21 recruiting
CHU de Reims21 recruiting
Baylor College of Medicine20 recruiting
King's College London20 recruiting
Geographic activity
United States66trials
France7trials
Sweden7trials
Switzerland5trials
China5trials
Canada5trials
United Kingdom4trials
Germany3trials
Turkey (Türkiye)2trials
Belgium2trials
India1trials
Brazil1trials
Leading interventions
Contingency Management2trials
Oxytocin2trials
Saline2trials
Acamprosate calcium1trials
Alc-IT (50/50) (morning)1trials
Alc-IT (75/25) (afternoon)1trials
Alc-IT (50/50) (afternoon)1trials
Amisulpride1trials
Analysis of executive functioning and of social cognition processes1trials
Analysis of social functioning and social cognition processes1trials
Assessment1trials
Alc-IT (75/25) (morning)1trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.